Skip to main content

Main menu

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics

User menu

  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart

Search

  • Advanced search
In Vivo
  • Other Publications
    • In Vivo
    • Anticancer Research
    • Cancer Genomics & Proteomics
  • Register
  • Subscribe
  • My alerts
  • Log in
  • My Cart
In Vivo

Advanced Search

  • Home
  • Current Issue
  • Archive
  • Info for
    • Authors
    • Advertisers
    • Editorial Board
  • Other Publications
    • Anticancer Research
    • Cancer Genomics & Proteomics
    • Cancer Diagnosis & Prognosis
  • More
    • IIAR
    • Conferences
  • About Us
    • General Policy
    • Contact
  • Visit iiar on Facebook
  • Follow us on Linkedin

Immune checkpoint inhibitor

  • Open Access
    Immune Checkpoint Inhibitors for Nasopharyngeal Carcinoma in a Real-world Setting in Japan
    TOMOMI MANAKO, RYUJI YASUMATSU, TAKAFUMI NAKANO, MIOKO MATSUO, TORANOSHIN TAKEUCHI, MASAHIKO TAURA, AKIHIRO TAMAE, MORIYASU YAMAUCHI, MUNEYUKI MASUDA, KENICHI TAGUCHI and TAKASHI NAKAGAWA
    In Vivo March 2023, 37 (2) 747-755; DOI: https://doi.org/10.21873/invivo.13137
  • Open Access
    Bevacizumab and Atezolizumab for Unresectable Hepatocellular Carcinoma: Real-world Data in Taiwan-Tainan Medical Oncology Group H01 Trial
    YANG-CHENG LEE, WEN-TSUNG HUANG, MING-YANG LEE, CHAO-JUNG TSAO and YIN-HSUN FENG
    In Vivo January 2023, 37 (1) 454-460; DOI: https://doi.org/10.21873/invivo.13099
  • Open Access
    Effect of Systemic or Intraperitoneal Administration of Anti-PD-1 Antibody for Peritoneal Metastases from Gastric Cancer
    YUKO KUMAGAI, YURIE FUTOH, HIDEYO MIYATO, HIDEYUKI OHZAWA, HIRONORI YAMAGUCHI, SHIN SAITO, KENTARO KURASHINA, YOSHINORI HOSOYA, ALAN KAWARAI LEFOR, NAOHIRO SATA and JOJI KITAYAMA
    In Vivo May 2022, 36 (3) 1126-1135; DOI: https://doi.org/10.21873/invivo.12811
  • You have access
    Immune Checkpoint Inhibitor Combination Therapy for Renal Cell Carcinomas With Concomitant Inferior Vena Cava Thrombi
    KAZUHIKO YOSHIDA, KEISUKE HATA, JUNPEI IIZUKA, TSUNENORI KONDO, HIROKI ISHIHARA, HIDEKI ISHIDA, YOJI NAGASHIMA, KAZUNARI TANABE and TOSHIO TAKAGI
    In Vivo March 2022, 36 (2) 1030-1034; DOI: https://doi.org/10.21873/invivo.12798
  • You have access
    Concomitant Proton Pump Inhibitors and Immune Checkpoint Inhibitors Increase Nephritis Frequency
    KOKI KATO, TOMOHIRO MIZUNO, TAKENAO KOSEKI, YOSHIMASA ITO, MASAKAZU HATANO, KAZUO TAKAHASHI, SHIGEKI YAMADA and NAOTAKE TSUBOI
    In Vivo September 2021, 35 (5) 2831-2840; DOI: https://doi.org/10.21873/invivo.12570
  • You have access
    Albumin-to-Alkaline Phosphatase Ratio as a Novel Prognostic Marker of Nivolumab Monotherapy for Previously Treated Metastatic Renal Cell Carcinoma
    MAKI YOSHINO, HIROKI ISHIHARA, YUDAI ISHIYAMA, HIDEKAZU TACHIBANA, DAISUKE TOKI, KAORI YAMASHITA, HIROHITO KOBAYASHI, HIRONORI FUKUDA, KAZUHIKO YOSHIDA, TOSHIO TAKAGI, JUNPEI IIZUKA, HIDEKI ISHIDA, TSUNENORI KONDO and KAZUNARI TANABE
    In Vivo September 2021, 35 (5) 2855-2862; DOI: https://doi.org/10.21873/invivo.12573
  • You have access
    Case Series of Pleomorphic Carcinoma of the Lung Treated With Immune Checkpoint Inhibitors
    KANA HAYASHI, KOTARO TOKUI, MINEHIKO INOMATA, KENJI AZECHI, ISAMI MIZUSHIMA, NAOKI TAKATA, CHIHIRO TAKA, SEISUKE OKAZAWA, KENTA KAMBARA, SHINGO IMANISHI, TOSHIRO MIWA, RYUJI HAYASHI, SHOKO MATSUI, SATOSHI NOMURA and KAZUYUKI TOBE
    In Vivo May 2021, 35 (3) 1687-1692; DOI: https://doi.org/10.21873/invivo.12428
  • You have access
    Efficacy of Paclitaxel-based Chemotherapy After Progression on Nivolumab for Head and Neck Cancer
    YASUYOSHI SATO, NAOKI FUKUDA, YU FUJIWARA, XIAOFEI WANG, TETSUYA URASAKI, AKIHIRO OHMOTO, KENJI NAKANO, MAKIKO ONO, JUNICHI TOMOMATSU, HIROKI MITANI and SHUNJI TAKAHASHI
    In Vivo March 2021, 35 (2) 1211-1215; DOI: https://doi.org/10.21873/invivo.12371
  • You have access
    Combination of Pembrolizumab With Platinum-containing Chemotherapy for Pleomorphic Carcinoma of the Lung
    SHINICHIRO OKAUCHI, YUIKA SASATANI, TOSHIHIRO SHIOZAWA, HIDEYASU YAMADA, KUNIHIKO MIYAZAKI, NORIO TAKAYASHIKI and HIROAKI SATOH
    In Vivo May 2020, 34 (3) 1439-1443; DOI: https://doi.org/10.21873/invivo.11926
  • You have access
    Analysis of Pleiotropic Effects of Nivolumab in Pretreated Advanced or Recurrent Non-small Cell Lung Cancer Cases
    YUMIKO AKANO, KOZO KURIBAYASHI, NORIHIKO FUNAGUCHI, YUICHI KODA, ERIKO FUJIMOTO, KOJI MIKAMI, TOSHIYUKI MINAMI, RYO TAKAHASHI, TAKASHI YOKOI and TAKASHI KIJIMA
    In Vivo March 2019, 33 (2) 507-514; DOI: https://doi.org/10.21873/invivo.11503

Pages

  • Next
  • 1
  • 2
In Vivo

© 2023 In Vivo

Powered by HighWire